Search

Byline: Ken Alltucker, USA TODAY Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, [...]

Byline: Reed Abelson and Rebecca Robbins In a report, the regulator sharply criticized pharmacy benefit managers, a turnaround from its longstanding tolerance of their practices. The Federal Trade Commission on [...]

BESSEMER: American Pharmacy Cooperative, Inc has issued the following press release: The country's largest pharmacy benefit managers (PBMs) are setting drug prices for patients at the pharmacy counter, and they [...]

Byline: Rob Lenihan To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/investing/bristolmyers-biogen-other-drugmakers-boost-prices-on-jan1-report Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Biogen (BIIB), and other [...]

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Retail Prescription Drug Prices Fall For First Time in 45 Years Retail prescription [...]

Chinas National Healthcare Security Administration (NHSA) has announced it has agreed an average 61% cut in prices of 70 top-selling drugs with large pharma manufacturers in exchange for inclusion on [...]

CHICAGO, IL -- The following information was released by the American Medical Association (AMA): Arbitration in determining prescription drug prices is a viable mechanism to address the burden of high [...]

LANSING: Michigan Pharmacists Association has issued the following press release: A new report released today by the Michigan Pharmacists Association and 3 Axis Advisors raises new questions about the role [...]

Following a truncated August recess, the House and the Senate returned to Washington after Labor Day with a full plate of legislative items to address prior to the end of [...]

WASHINGTON, DC -- The following information was released by the American Hospital Association (AHA): by Ashley Thompson is AHA Senior Vice President of Public Policy Analysis and Development The Pharmaceutical [...]

The rising cost of pharmaceuticals is a concern for people in all parts of the world, leading to some to forecast the spiralling costs are unsustainable. New technologies may hold [...]

Pharma companies ended 2017 with prices down, not up, according to analysts at SSR Health. Net pricesafter rebates and discountsslipped 1.1% in the fourth quarter, the analysts calculated, despite overall [...]

Retail prices of various syringes are on average marked up as much as 664% from the price at which distributors purchase them, a new report by the National Pharmaceutical Pricing [...]

2020 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Research findings on Economics - Pharmacoeconomics are discussed in a new report. According to [...]

UBS found that Teva has put up the prices of both generic and branded drugs but not its flagship multiple sclerosis treatment. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) [...]

M2 PRESSWIRE-December 1, 2017-: NAS issues recommendations to lower drug prices (C)1994-2017 M2 COMMUNICATIONS RDATE:30112017 The National Academies of Science, Engineering and Medicine released a report arguing that the biopharmaceutical [...]

WASHINGTON, D.C. -- The following information was released by the Pharmaceutical Care Management Association: As the Senate Committee on Health, Education, Labor and Pensions examines the drug delivery system during [...]

Byline: William McConnell To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/story/14182849/1/trump-officials-get-to-work-on-lowering-drug-prices.html Senior Trump Administration health and budget officials are meeting Friday, [...]

NEW YORK, May 10, 2017 /PRNewswire/ -- As legislative debate continues to contemplate the future of healthcare, prescription drug prices soared 8.77% in 2016, representing the fourth consecutive year of [...]

Network newscasts have all but ignored skyrocketing prescription drug prices at a time when Americans say high costs are their top health care concern and three-quarters of Americans want to [...]

WASHINGTON -- The following information was released by Vermont Senator Bernie Sanders: Network newscasts have all but ignored skyrocketing prescription drug prices at a time when Americans say high costs [...]

Byline: Carolyn Y. Johnson This is embargoed online until midnight Friday. The average annual retail cost of specialty drugs used to treat complex diseases such as cancer, rheumatoid arthritis and [...]

Byline: mirror Pharmaceutical firms are 'milking' the NHS by hiking drug prices by 2,000%, it has been claimed. Companies are said to be 'de-branding' vital medication and flogging them as [...]

More Than One-Third of Medicine List Prices Are Rebated Back to Payers and the Government or Retained by Stakeholders in Biopharmaceutical Supply Chain Only 47 Percent of Total U.S. Prescription [...]

PARIS, France -- The following information was released by the Organisation for Economic Cooperation and Development (OECD): The proliferation of high-cost medicines and rising drug prices are increasing pressures on [...]

Byline: Carolyn Y. Johnson The skyrocketing costs of prescription drugsÃáhasÃábeen noticeably absent from discussionÃáin theÃápresidential debatesÃáÇöÃáeven as bipartisan anger about price gouging has united Congress. But the trade group for [...]

WASHINGTON -- The following information was released by the office of Nebraska Rep. Jeff Fortenberry: Awhile back I visited the dermatologist due to a sore spot that would not heal. [...]

WASHINGTON, DC -- The following information was released by AARP: AARP announces its support for the bipartisan FAIR Drug Pricing Act of 2016. The legislation, introduced today, by U.S. Senators [...]

ST. LOUIS -- RGA Reinsurance Company, a subsidiary of Reinsurance Group of America, Incorporated, (NYSE: RGA) today released a report identifying 183 high-cost specialty drugs, defined as costing greater than [...]

Herzliya: XTLbio has issued the following news release: fter getting beaten up last week over the pricing of its hepatitis C treatments in the United Kingdom, Gilead Sciences is going [...]

Byline: Carolyn Y. Johnson A battle for profits between two armsÃáof the health-careÃáindustry has madeÃáprivately insured patients intoÃápawns, offering them a growing number of discounts on theirÃádrugÃáco-pays whileÃáultimately leaving themÃáwithÃáfewer [...]

Truveris' OneRx ([R] ) Digital Solution Supports Medication Adherence by Maximizing Prescription Drug Savings for Both Insured and Uninsured NEW YORK -- Consumers increasingly walk away from prescription drugs that [...]

Rockville, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Zachary Brennan The complicated world of drug pricing presents an array of challenges for keeping [...]

M2 PRESSWIRE-March 26, 2015-: New WHO report shows that transparency and cooperation help to reduce high prices for new medicines (C)1994-2015 M2 COMMUNICATIONS RDATE:26032015 Copenhagen - As the number of [...]